We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Skinbiotherapeutics Plc | SBTX | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.50 | 2.04% | 25.00 | 14:17:14 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 24.50 | 24.50 | 25.00 | 25.00 | 24.50 |
| Industry Sector |
|---|
| PHARMACEUTICALS & BIOTECHNOLOGY |
| Top Posts |
|---|
Posted at 13/3/2025 07:03 by sunshine today Good morningA quick recap, as the launch date draws in. How undervalued is SBTX, who own the IP of a product that’s potentially about to change the 🤪 FACE of the world, for ever. ? A product that’s being produced, and sold, by the world’s number ONE supplier of anti ageing cosmetics ingredients. Think : how easy it is for Croda to sell to their 12,000 customers, a vastly improved green sustainable bio anti ageing, ( and more ), product. Think : how difficult it is for any new ingredient supplier, not only catch up with Croda, but more to the point , make sales. Sales are extremely slow for new players to the market as they are never trusted. Croda has data sheets on your desk within the hour . These are so detailed : V what’s offered by others . Please to the Croda web site for more on this subject. Thus , even if a decent product was produced by the competition, its adoption often gets swamped, and it never sees the light of day . Croda has a product that has pricing power, combined with an end user consumer target market, of over HALF the world’s population. Backed by a FTSE 100 company who pays out cash to SBTX, on every sale, before it deducts its own overhead costs. ! Unreal , that SBTX had the clout to get that agreed , plus the right to buy back the Lysate for use outside cosmetics, as just above cost. SBTX has five pillars, all of which could be roaring on all five cylinders, within just 5-10 years. SBTX is on the verge of going cash flow positive , without any Croda income. |
Posted at 12/3/2025 07:07 by sunshine today Good morning :Just under 4 weeks to go. SBTX Revenue growth , and projected revenue £132,000 2023 £1.2M 2024 £5.3 M. 2025. (Company guidance ). SBTX directors have not been sleeping. For seasoned investors, it points to great things to come. It’s these types of growth rates that , when purchased early, can go on and deliver outstanding share holder returns. By July 1st 2025 , SBTX is projected by the directors to be cash flow positive , ( without any potential fast growing , recurring royalties from Croda, or any additional deals or agreements. ——— Today I am going to make a bold prediction, (a dangerous game ,at the best of times.) Tax free Profits from SBTX in the year July 2025 to June 30 2026 will = SBTX turnover of the previous year ( 2024 - 2025). This is based ( in part ),on the new information to me, posted here yesterday ( potential deals for the Lysate outside of cosmetics.) I see a good chance in my view the same pattern could be archived the following year, namely profits matching the previous years turnover. This would highly unusual , exceptional, requiring the new Lysate to be a true blockbuster. Croda is a massive company with huge ambition to get its operating margins back up to 25%. They have the resources to do just that. Finally if you’re reading this, your way, way, ahead of the crowd, try to get any trading mentality out of your head, it’s not the way to win in this game. Just ask the worlds master :warren Buffett . |
Posted at 11/3/2025 08:40 by sunshine today Grok AICourtesy the Lemming Investor site. For those who would like more very detailed research on SBTX you might like to take a look . As with Tom Winnerfrith, who also writes on SBTX, it will cost you , but in the scheme of things well worth it in my view . WARNING //////////////// None of this should be relied on : THE FOLLOWING IS ALL TOTALY computer generated. SkinBioTherapeutics (SBTX): The top growth pick (5–25x, £150M–£850M by 2030). FY 2025’s £6.3M launches a trajectory to £25M–£85M, driven by Croda’s lysate (£10M–£50M royalties) non-cosmetic ventures (£10M–£30M) and Umesh Modi’s AMEA expansion (£5M–£15M). Regulatory tailwinds (e.g., peptide scrutiny) and cash to mid-2026 ensure execution. Best for aggressive investors seeking outsized returns. //////////////////// This is how I decipher the above. My own numbers are in the same ball park, bearing in mind, how difficult it is to forecast anything. THE HUGE TAKEAWAY BEING : //////////////////// THE RESULTS FROM AI WILL NOT HAVE GONE-OVER THE TOP TO ENTICE INVESTORS TO BUY. ITS NOT GEARED TOWARDS A SALES PITCH THE RESULTS COULD BE WAY OFF THE MARK : UP OR DOWN. Even if one assumes all the numbers are way to high,( let’s say by an 80% margin,) SBTX would still be a BUY and hold that would beat the market hands down BY 2030 We have just 5 years to see just how clever Grok is. ( or is not ). |
Posted at 10/3/2025 09:03 by sunshine today Could SBTX shock the market and produce a profit this year ending on 30/06/25. ?We will get some clues later in the month when SBTX interims are published . The broker has SBTX down for an adjusted loss of £1.5M I list possible reasons why shareholders could be in for a possible, nice surprise. 1/ One, or more new agreements being signed, with an up front fee, being paid to SBTX. 2/ Croda revenues expanding at pace. 3/ Cost savings, and growth, from the two new companies purchased last year. 4/ Bulk sales of the Lysate produced by Croda and sold by SBTX to third parties outside of cosmetics. 5/ Any other reason, I am not smart enough, to think of .! |
Posted at 09/3/2025 19:07 by x anon sunshine Today9 Mar '25 - 14:34 - 248 of 248SBTX : End consumer market : over half the world’s population. Operating margin from Croda 99% ( the SBTX overhead base is covered by the new companies purchased in 2024.) If SBTX can land another two Croda style deals, from the Lysate, you will own a company like no other. Shares like this are rare,the work has been done, super fast profit growth is built in. Recurring revenues , bar the initial agreements, SBTX has zero input costs. Investors will flock here. ................ ................ ................ I think he is underplaying it. But i noted this :... 'If SBTX can land another two Croda style deals, from the Lysate, you will own a company like no other.' .......... Just to confirm. are we talking about the same lysate CRDA are supposed to be using in a new product ? |
Posted at 09/3/2025 14:34 by sunshine today Games Workshop 4.7Bn market cap.Trading update last week Some 4.7 million people now use the Warhammer community website, it said, an increase of 200,000 on the same period last year. Operating margin; 35% A true stock market darling . ——— SBTX : End consumer market : over half the world’s population. Operating margin from Croda 99% ( the SBTX overhead base is covered by the new companies purchased in 2024.) If SBTX can land another two Croda style deals, from the Lysate, you will own a company like no other. Shares like this are rare,the work has been done, super fast profit growth is built in. Recurring revenues , bar the initial agreements, SBTX has zero input costs. Investors will flock here. |
Posted at 09/3/2025 09:56 by netcurtains I agree with Sunshine Todays point...If LYSATE works and a big company offered me 40p a share I would do the sums myself and come up with a price of £1.20 However Croda dont make the COSMETIC they make the INGREDIENTS so at best we're talking 10% of the WHOLESALE price.... Best case: £30M a year given to SBTX as commission (if LYSATE matches other wonder ingredients)... £30M commission should give SBTX a market cap of about £300M to £900M - if SBTX have no other products to sell... (obviously £30M commission is not year one - I mean a few years down the line) But if LYSATE tanks then the current price of SBTX might be a tad bit high.... Not sure. Current price assumes SBTX can make about £1M to £3M profit a year.. |
Posted at 20/2/2025 08:07 by sunshine today 47 days to goGood morning SBTX is now hitting the radar, of a handful more investors. Based on my previous experience on chasing potential 100 baggers. ;; This is what tends to happen when a grossly undervalued micro cap, begins to hit the limelight. We will know when that truly occurs , the share's move in lumps of over 10p, a day. I expect one, or more, earthquakes, and several tidal waves, in 2025. The earthquakes occur when the city boys cotton on to the earnings potential of SBTX. ( my experience is that they are always very slow off the mark, every single time.) The tidal wave is when end users start promoting the products, amongst themselves, sending sales through the roof. The potential end consumer market , is, after all, half the worlds population The third stage sees the shares rated for perfection in perhaps 3-5 years time. The growth rate starts to slow , and the shares become a bore. That’s where the real grind sets in , for those attempting to 100 bag. Just 230M shares in issue , from now on , it’s a case of finding a willing seller, which I am afraid gets harder, to do , over time. The pool of shares for trading, slowly, but surely, gets tucked away, ensuring a very long term ,gentle squeeze , ( years ), preventing the Market Makers playing the standard ploy they like to dosh out , to those holding the shares. That is a tactic of slashing the bid price whenever they can, to put the frighteners on shareholders, in an attempt, to pick up stock , ( that they have sold short, at higher prices ). SBTX is not a trading share, it’s a company with growth prospects, like no other. Normally it’s the micro cap working on thin margins for the giant, here it’s FTSE 100 Croda, posting a super fast growing, fat cheque , to SBTS on the last day of each month. The real fun does not start until the crowd shows up , that is still months away , no matter how well the share performs, in the meantime. It’s all about numbers, SBTX unheard of today, prior to the launch. SBTX will gain a following , as the recurring nature of the profits, combined with super fast growth fast growth makes the shares an attractive asset to own. Some can’t see it now, trust me , they will. |
Posted at 14/2/2025 07:07 by sunshine today Good morning .53 days to go. Today I look into what SBTX interim results might look like. Due to be published in March. The broker has a full year loss of £1.5M Most of that loss will have been built into the first half in my view. Thus , on paper we could be looking at perhaps a loss of £1.2M - £1.3M for the first 6 months. //////////////////// However this excludes any potential revenues from Croda. A few thoughts NOT based on facts. We do not know ALL the terms of the 2019 Croda agreement . We also don’t know the extension terms on the agreement for one year, agreed in 2023. It strikes me shareholders may be missing a trick here. ( barking up the wrong tree ). WHY : Shareholders are looking for the first Croda income to show in the interim results , some say from samples, others from the first orders. My take is it MIGHT NOT be any of those. If I was signing an agreement in 2019 I would set an end project date in stone , that date may have been 2,3,4, or 5 years. The clues here, past SBTX news items , first revenues were expected a very long time ago. !! I would also set out the criteria for delivery, ie, just how many of the properties required from the product have been achieved. Finally any enhancements over and above what was required from the product. //////////////////// 1/ SBTX might to due some penalty fees for late delivery to market. 2/ SBTX might be due one off project completion revenue, as the product was proved to do what it says on the tin. ( and more ) 3/ The new agreement signed late last year may allow for a SBTX to pick up a one off fee for extending timelines going forward, and other confidential details. |
Posted at 10/2/2025 08:14 by sunshine today Good Morning57 days to go. Crunching the Croda numbers, for it is they , who require the Lysate to make them hundreds of millions of fast growing , recurring revenues . SBTX gets 10% (or more) on sales on behalf of SBTX ,made by Croda . Less assume it’s 10% ( to make the sums easy ) Croda wants clear profit of 30P in the pound , on new and protected products . Let’s start with £10 of sales £1 is sent off to SBTX That leaves £9.00 Less CRODA’S Materials and labour @45% for production. £5.00 left Less Croda overheads @33% £3.33 net profit for Croda. Knock off the 33p for safety. Matrixyl the product being replaced , made and sold by Croda , sells around £350M a year. At the rate above Croda should make £117M per year net . SBTX could make £35M @10% ……… Todays SBTX market cap stands in a tad over £35M Earnings could = today’s market cap in a few short years. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
